Evan Raff
Impact in
- Hepatology top 10%
- Liver Disease and Transplantation
- Liver Diseases and Immunity
- Hepatocellular Carcinoma Treatment and Prognosis
- Hepatitis C virus research
-
- Liver Disease Diagnosis and Treatment
Papers in
-
- Hepatocellular Carcinoma Treatment and Prognosis 2
- Co-authors
- Ashwani K. SingalMohamed ShoreibahJoseph R. BloomerKhalid RasheedCarl M. KjellstrandPhilip F. HalloranYong‐Fang KuoHans Dieter Nischalke
- Journals
- The American Journal of Gastroenterology (2 papers)Clinical Journal of the American Society of Nephrology (1 paper)American Journal of Medical Quality (1 paper)Current Opinion in Nephrology & Hypertension (1 paper)ASAIO Journal (1 paper)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Evan Raff
17 papers receiving 300 citations
Peers
Comparison fields: 5 of 51
- Hepatology 115
- Epidemiology 232
- Pathology and Forensic Medicine 109
- Endocrinology, Diabetes and Metabolism 86
- Pharmacology 17
Countries citing papers authored by Evan Raff
This map shows the geographic impact of Evan Raff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evan Raff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evan Raff more than expected).
Fields of papers citing papers by Evan Raff
This network shows the impact of papers produced by Evan Raff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evan Raff. The network helps show where Evan Raff may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Evan Raff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 0 | |
| 7 | 2023 | 2 | |
| 8 | 2022 | 1 | |
| 9 | 2022 | 6 | |
| 10 | 2017 | 22 | |
| 11 | 2017 | 3 | |
| 12 | 2017 | 0 | |
| 13 | 2015 | 75 | |
| 14 | 2015 | 31 | |
| 15 | 2015 | 120 | |
| 16 | 2014 | 1 | |
| 17 | Optimal management of alcoholic hepatitis. | 2014 | 5 |
| 18 | 2014 | 2 | |
| 19 | 2005 | 2 | |
| 20 | Renal failure after eating "magic" mushrooms. | 1992 | 32 |
About Evan Raff
Evan Raff is a scholar working on Hepatology, Family Practice, Emergency Medicine, Endocrinology, Diabetes and Metabolism and Pathology and Forensic Medicine, having authored 20 papers that have together received 308 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (7 papers), Alcohol Consumption and Health Effects (5 papers), Diet, Metabolism, and Disease (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Emergency and Acute Care Studies (2 papers), Migration, Health and Trauma (2 papers), Healthcare Policy and Management (2 papers) and Interpreting and Communication in Healthcare (2 papers). The work is most often cited by research in Hepatology (115 citations), Epidemiology (232 citations), Pathology and Forensic Medicine (109 citations), Endocrinology, Diabetes and Metabolism (86 citations) and Pharmacology (17 citations). Evan Raff has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Ashwani K. Singal, Mohamed Shoreibah, Joseph R. Bloomer, Khalid Rasheed, Carl M. Kjellstrand, Philip F. Halloran, Yong‐Fang Kuo, Hans Dieter Nischalke, Pierluigi Toniutto and Stefano Ginanni Corradini. Their work appears in journals such as The American Journal of Gastroenterology, Clinical Journal of the American Society of Nephrology, American Journal of Medical Quality, Current Opinion in Nephrology & Hypertension and ASAIO Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.